Skip to Content

Soltamox Savient Pharmaceuticals, Inc. - Treatment for Breast Cancer

Soltamox is an oral liquid formulation of tamoxifen, indicated for the treatment of breast cancer in adjuvant and metastatic settings and to reduce risks of breast cancer in women with ductal carcinoma in situ (DCIS) and reduction of breast cancer incidence in women with high risk of breast cancer.

Posted: October 2005

Related Articles:

Soltamox (tamoxifen) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.